Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genoskin’s ex vivo human skin platforms are validated as reliable alternatives to animal testing for toxicity and efficacy assessment of drugs, vaccines, medical devices, cosmetics, and chemicals. Their models have been used in published studies demonstrating utility in wound healing and infection models. The company enables generation of authentic human data before clinical trials to de-risk development programs. No clinical results as the company does not develop therapeutics itself.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genoskin.